The Eradication of Poliomyelitis in Egypt: Critical Factors Affecting Progress to Date

Size: px
Start display at page:

Download "The Eradication of Poliomyelitis in Egypt: Critical Factors Affecting Progress to Date"

Transcription

1 S56 The Eradication of Poliomyelitis in Egypt: Critical Factors Affecting Progress to Date R. Bruce Aylward, Esmat Mansour, EI Said Aly Don, Ahmed Haridi, Abdulla Abu EI Kheir, and AtefHassan World Health Organization, Geneva, Switzerland; Child Survival Project and Department of Communicable Disease Control, Ministry of Health, Cairo, Egypt Poliomyelitis eradication activities in Egypt were reviewed to identify the critical factors for the progress seen by 1995 and to highlight problems that could be avoided in other countries in which poliomyelitis is endemic. National immunization and surveillance data demonstrate that the combination of high routine immunization coverage' (>85%) with oral polio vaccine combined with two properly conducted rounds of national immunization days (NIDs) resulted in a 75% reduction in reported polio cases between 1992 and Available data suggest that earlier control strategies, such as single-round NIDs in 1990 and 1991, the administration of inactivated poliovirus vaccine (IPV) at 2 months of age in , and the use of "mop-up" campaigns while wild poliovirus was still widespread, did not contribute substantially to the recent decline in cases. Proper implementation of the World Health Organization's recommended strategies can eliminate wild poliovirus circulationin the large, densely populatedtropicalcountriesin which poliomyelitis remainsendemic. In 1988, the World Health Assembly voted to eradicate wild polioviruses by the year 2000 [1]. The technical feasibility of the goal was confirmed in September 1994, when an international commission certified that wild poliovirus has been eliminated from the Western Hemisphere [2]. Despite such progress, the disease remains endemic in a number of large, densely populated countries in Asia and Africa [3, 4]. Continued circulation of wild polioviruses in such countries poses a threat to both local populations and regions that have already eliminated the virus [2, 5]. Egypt is one poliovirus-endemic country where the early interruption of wild poliovirus circulation has been an international priority [6]. Ongoing efforts to establish a large block of polio-free countries stretching from the Magreb countries of North Africa to the Arab States of the Gulf depend on progress in Egypt [7]. Additionally, molecular characterization of wild polioviruses has indirectly linked Egyptian strains with distant cases in other parts ofthe world. Despite a long history of polio control activities and a strong childhood immunization program, poliomyelitis remained widely endemic in Egypt until quite recently [8], leading to questions as to the feasibility of polio eradication. Here we review the epidemiology of polio in Egypt through 1995, demonstrating that once the recommended strategies of Financial support: This study was supported by the US Agency for International Development through the technical assistance contract of Clark Atlanta University (AID # ) with the Egyptian Ministry ofhealth Child Survival Project, Cairo, Egypt. The views presented are those of the authors. Reprints or correspondence: Dr. R. Bruce Aylward, Expanded Programme on Immunization, Global Programme for Vaccines and Immunization, World Health Organization, 20 Ave. Appia, 1211-Geneva-27, Switzerland. The Journal oflnfectious Diseases 1997;175(Suppll):S by The University of Chicago. All rights reserved /97/ $01.00 the World Health Organization (WHO) are properly implemented, widespread poliovirus circulation can be interrupted within 2 or 3 years. The experience in Egypt is used to illustrate problems that might be avoided in the remaining polio-endemic countries as they undertake eradication programs. Background Based on the extrapolation of 1986 census data, the 1994 population of Egypt was 59,000,000, with million births annually. Administratively, there are 27 governorates, which are further divided into 223 districts (218 and 214 in 1992 and 1993, respectively). Twenty-five percent ofthe population is concentrated in the 3 governorates that constitute greater Cairo (Cairo, Giza, Qalyoubia). The percentage of the total population living in the Nile Delta (8 governorates), Upper Egypt (8 governorates), and other governorates (8) is 43%, 28%, and 4%, respectively. About 15% of the population is < 5 years old and 42% is < 15 years old. In summary, the WHO-recommended strategies for polio eradication from countries in which poliomyelitis is endemic consist of high routine infant immunization with at least three doses of oral polio vaccine (OPV3), national immunization days (NIDs) and "mopping up," and surveillance for acute flaccid paralysis (AFP) [9-11]. During NIDs, all children <5 years old should receive two OPV doses 1 month apart, regardless of their prior immunization status, in the low season for polio transmission [9]. Mopping up, consisting of two rounds of house-to-house immunization, should be conducted in geographically restricted high-risk areas [12] after NIDs have reduced wild poliovirus transmission to focal areas. To rule out ongoing wild poliovirus circulation, all AFP cases among children < 15 years old should be investigated [13], with the analysis of 2 properly collected stool specimens in an accredited laboratory [14].

2 JID 1997; 175 (Supp1 1) Polio Eradication in Egypt S57 Monthly reported cases of polio 500r-r , Figure 1. Immunizationcampaigns with oral polio vaccine (OPY) and reported cases of poliomyelitis by month, Egypt, * No. of arrows correspondsto no. ofimmunization rounds conducted. Routine = routine OPV doses delivered by national or subnational campaigns. NIDs = supplementary OPV doses delivered during national immunization days. Mop-up = supplementary OPV doses given house-to-house in high-risk areas Campaigns* 1 Routine.+. NICs 'Mop-up' II Polio cases o Immunization in Egypt before the Eradication Initiative Polio has been a recognized health problem in Egypt since the time of the Pharaohs; an Egyptian tombstone from the year 1500 B.C. contains the first known illustration or record of a case. Before obligatory childhood immunization was instituted nationwide in 1968, the annual incidence of paralytic polio was estimated to be cases/100,000 total population on the basis of records from the National Polio Institute. Although 65% of the infants were being immunized against polio by 1975 and the incidence of the disease had fallen to 6.5 cases/ 100,000 population, >2000 cases continued to be reported annually. While routine immunization services were being developed, eight OPV campaigns were conducted to achieve and maintain high OPV3 coverage (figure 1). In the late 1970s, the campaigns consisted of one to three immunization rounds conducted over days and separated by an interval of6-8 weeks. After the first campaign, the estimated number ofpolio cases per 100,000 total population fell to 1.5 in When the campaigns were stopped in favor of strengthening routine immunization services in 1979, the incidence of polio immediately began to rise such that by the end of 1980, cases had returned to the pre-1976 level. This abrupt increase in cases, combined with a slower-thanexpected rise in routine immunization coverage, led to a resumption of the OPV campaigns on an annual basis from 1983 to In contrast to the 1970s, the incidence of polio did not increase following the cessation of the campaigns in 1987, primarily because high OPV3 coverage was being maintained through routine immunization services by that time (figure 2) (an acceleration of the national Expanded Programme on Immunization [EPI] in 1984 had led to a substantial infusion of resources to ensure that at least 80% of infants were being fully immunized by 1990). Between 1987 and 1992, the number of reported cases of polio remained relatively stable at per year. Wild poliovirus circulation continued to be widespread, however, as cases were still being reported from 70% of districts in The Poliomyelitis Eradication Program in Egypt: In 1989, President Hosni Mubarak declared that polio eradication would be a primary goal of the 1990s Decade of the Protection and Development ofthe Child in Egypt [15]. In July of that year, the Ministry of Health established a national polio eradication committee, and a "polio control room" was created in 1991 to coordinate activities. Four NIDs were undertaken between 1990 and 1994 to interrupt wild poliovirus transmission. In contrast to earlier campaigns, OPV3 coverage was already >90% and polio incidence was at an historic low (figure 2). During the NIDs, supplementary OPV doses were administered to all children <5 years old in 1990 and 1991 and <4 years old in 1993 and Because of the limited impact of a single NID round in 1990 and 1991, two rounds were conducted during the low season for poliovirus transmission in 1993 and 1994 (figure 1, table 1). Although poliovirus circulation was still widespread in Egypt by 1990, a decision was made to introduce geographically targeted mop-up campaigns in an attempt to accelerate the eradication program in the highest-risk districts. A total of three mop-up campaigns were conducted between 1991 and Immediate reporting and standardized investigation of all AFP cases began in August 1990, with an emphasis on the timely collection of 2 stool specimens for virologic studies and

3 SS8 Aylward et al. nn 1997; 175 (Supp1 1) Reported Cases of Polio OPV3 Coverage* 2,500, ,100% 2,000 80% 1,500 1,000 60%... 40% Key [J Polio Cases +OPV3 (%) Figure 2. Reported cases of poliomyelitis and infant immunization coverage with 3 doses of oral poliovirus vaccine (OPV3), Egypt, (nationwide Expanded Programme on Immunization was established in 1980). * Does not include supplementary doses given through national immunization days. 500 ~... H 11.: fi I 20% a 60-day follow-up examination for residual paralysis. In 1990, the National Institute for Vaccines and Sera in Cairo joinedthe Global Polio LaboratoryNetwork as a WHO regional reference laboratory. Beginning in January 1992, all health facilities were required to file a weekly "zero report" if no cases were seen (until 1987, national polio data consisted only ofcases reported from the National Polio Institute). A telex system was established to allow each governorate to send a daily AFP telex to the polio control.room in Cairo. By 1993, every reported AFP case had a laboratory investigation and every patient had a follow-up examination (table 2), and all polio cases were confirmed by virus isolation, residual paralysis, death, or loss to follow-up, rather than on the basis of one clinical examination. In 1991, authorities in Egypt recommended that children should receive a single dose of inactivated poliovirus vaccine (IPV) at 2 months of age because ofspeculation that suboptimal seroconversion was contributing to the continued widespread circulation of wild poliovirus [16]. As a result,,..., 1.5 million children received a dose of IPV in 1992 and in The single-dose IPV strategy was discontinued in 1994, however, because of financial constraints and concerns as to its efficacy. TheImpact of Polio Eradication Activities in Egypt Although the reported number of polio cases fell significantly following the OPV campaigns ofthe 1970s and the EPI acceler- Table 1. Selected characteristics of nationwide oral polio vaccine (OPV) immunization campaigns, ranked by associated reduction in cases, Egypt, % reduction Total Low' Weeks Target age Total doses in polio immunization season between group ofopv cases* rounds rounds rounds (months) (millions) , * % reduction in polio cases between 12-month periods immediately before and after end of each campaign (negative result indicates increase in reported cases). t High season for enterovirus circulation in Egypt is May-November.

4 JIO 1997;175 (Suppl1) Polio Eradication in Egypt S59 Reported Polio Cases 100r , Figure 3. Reported cases of poliomyelitis by month of onset, Egypt, lill *1993 OL l Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Month ation of the 1980s, it was not until 1993 that there was a significant restriction in the geographic distribution ofthe virus [8]. In 1993, 150 polio cases were reported from 33% of the districts, compared with 584 cases from 69% of districts in The lack of a seasonal variation in polio incidence in 1993 also suggests that widespread circulation ofthe virus was interrupted in that year (figure 3). Despite further improvements in AFP surveillance, polio cases continued to decline, to 120 cases in 24% of districts in 1994 and 71 cases in 21% of districts in The recent progress toward polio eradication in Egypt seems primarily due to the NIDs that were conducted in 1993 and A number of factors distinguish these NIDs from previous campaigns (table 1). Compared with the campaigns of the 1970s and 1980s, the NIDs included newborns, were conducted when routine immunization was already > 85%, and were completed in a shorter period of time. In contrast to the NIDs of , the NIDs consisted of multiple rounds and, as op- Table 2. Improvement in performance of acute flaccid paralysis (AFP) case investigation as monitored with standard indicators, Egypt, Total AFP cases % reported within 48 h % investigated within 48 h of report % with ;:;,1 specimen collected % with 60-day follow-up examination posed to virtually all previous campaigns, both rounds were conducted in the low season for poliovirus circulation. In addition, the number of OPV doses administered per round in 1993 was much higher than in previous years, suggesting that the immunization coverage achieved was also substantially higher. The mop-up campaigns did not contribute significantly to the observed decline in polio. The reduction in cases among high-risk districts that did or did not conduct mop-ups was similar (78% and 78%, respectively, in 1991, and 29% and 27%, respectively, in 1992). In retrospect, it was very unlikely that these mop-ups could have interrupted polio transmission, as they were conducted in relatively small geographic areas while wild poliovirus circulation was still widespread [17]. Because only the highest-incidence districts were included in the mop-ups, the virus could have been readily reintroduced from contiguous low-incidence districts or other high-risk districts that were not identified because of poor surveillance. The addition of a single dose of IPV to the immunization schedule at 2 months of age probably did not playa substantial role in the interruption of poliovirus circulation. Based on the finding that only 50% of polio cases had received OPV3 in 1990 and 1992, the efficacy ofopv was estimated to be >90% [18]; cases were primarily due to a failure to vaccinate children rather than vaccine failure. The introduction of IPV in did not address this problem, and IPV probably reached the same infants as were already receiving OPV3. A comparison of confirmed and discarded polio cases for the period showed no difference in the proportion of children who had received IPV, after controlling for age, OPV history, and sex, suggesting that IPV at 2 months ofage conferred no additional protection (personal communication: Linkins R, CDC, Atlanta).

5 S60 Aylward et al. JID 1997; 175 (Suppl 1) Table 3. Expected and reported number of nonpolio acute flaccid paralysis (AFP) cases, by region, Egypt, Expected Reported 1994 Region (no. of population nonpolio nonpolio nonpolio governorates) (millions) AFP cases* AFP cases AFP rate Cairo area (3) Nile Delta (8) Upper Egypt (8) Other (8) Egypt (27) * Expected rate of nonpolio AFP is> 1 case/100,000 population < 15 years old. Current Priorities of the Polio Eradication Initiative At this point in the polio eradication program in Egypt, improved AFP surveillance and accurate diagnosis of cases are needed to confirm achievements and ensure that future supplementary immunization activities are properly targeted. The highest priority is to ensure that all cases ofafp, including nonpolio conditions such as Guillain-Barre syndrome, are reported and investigated. In 1994, the national nonpolio AFP rate was 0.34 cases/l00,000 population < 15 years old, substantially lower than the minimum expected rate of 1 caseiloo,ooo [9]. The lack ofnonpolio AFP cases in certain geographic areas indicates that surveillance must be improved to confirm the absence of polio (table 3). The low AFP rate is primarily due to a failure to report nonpolio paralytic conditions in children 5-15 years old. Improved reporting requires a closer working relationship between public health officials and clinicians and active surveillance to regularly search for AFP cases in the main hospitals of each governorate. The accuracy of polio diagnosis must also be improved. Intratypic differentiation should be performed on all poliovirus isolates to distinguish between wild and vaccine strains. Additional resources could then be allocated for supplementary immunization activities in areas where wild poliovirus is known to persist. NIDs must be conducted for at least another 2 years, after which the need for further nationwide OPV campaigns can be reassessed. Mopping up should only be conducted when the performance of AFP surveillance is sufficient to confirm that wild poliovirus transmission has been limited to focal geographic areas, if not interrupted completely. Lessons for Poliovirus-Endemic Countries The experience with implementing a polio eradication initiative in Egypt illustrates a number of important points for other poliovirus-endemic countries. First, achieving and sustaining high routine immunization coverage is an important determinant ofthe success ofnids; in the absence of a strong routine program, NIDs may need to be continued indefinitely. Second, high-quality NIDs must be the priority while wild poliovirus circulation remains widespread. Third, mop-up immunization should be reserved until there is high-quality AFP surveillance demonstrating that wild poliovirus circulation has become geographically restricted. Conclusions The recent progress toward polio eradication in Egypt demonstrates that wild poliovirus circulation can be interrupted in densely populated tropical countries with suboptimal sanitation if the globally recommended strategies are properly implemented. It is particularly important, however, that NIDs be of a consistently high quality in all geographic areas to stop widespread low-level poliovirus circulation. Establishing AFP surveillance provides a quantifiable means of monitoring progress and confirming achievements through the use of internationally standardized indicators. The ultimate success of the global polio eradication initiative does not require substantial modification of these strategies. Proper implementation of the existing strategies, however, in the few areas of the world in which poliomyelitis remains highly endemic is the key to the successful eradication of this disease. Acknowledgments We thank Nick Ward and Harry Hull (WHO), Steve Cochi (CDC), and Frank Cummings (Clark Atlanta University, Atlanta) for manuscript review. References 1. World Health Assembly. Global eradication of poliomyelitis by the year Geneva: World Health Organization, 1988; WHA resolution no. WHA Expanded Programme on Immunization. Certification of poliomyelitis eradication-the Americas, Wkly Epidemiol Rec 1994;69: Patriarca PA. Polio outbreaks: a tale of torment. Lancet 1994;344: Expanded Programme on Immunization. Poliomyelitis in Wkly Epidemiol Rec 1994;69: Robbins Fe. Eradication ofpolio in the Americas. lama 1993;270: Ward NA, Milstien JB, Hull HF, Hull BP. A global overview and hope for the eradication of poliomyelitis by the year Trop Geogr Med 1993;45: Expanded Programme on Immunization. Progress towards poliomyelitis eradication-egypt. Wkly Epidemiol Rec 1994;69: Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication-egypt, MMWR Morb Mortal Wkly Rep 1993;43: Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros e. Paralytic poliomyelitis; seasoned strategies, disappearing disease. Lancet 1994; 343: Wright PF, Kim-Farley RJ, de Quadros CA, et al. Strategies for the global eradication ofpoliomyelitis by the year N Engl 1 Med 1991;325:

6 JID 1997;175 (Suppll) Polio Eradication in Egypt S61 II. de Quadros C, Andrus JK, Olive 1M, et al. Eradication of poliomyelitis: progress in the Americas. Pediatr Infect Dis J 1991; 10: Expanded Programme on Immunization. Global Advisory Group-Part 1. Wkly Epidemiol Rec 1991;66: Andrus JK, de Quadros C, Olive JM. The surveillance challenge: final stages ofthe eradication of poliomyelitis in the Americas. MMWR CDC Surveill Summ 1992; 41(S8-1): Ward NA, Milstien JB, Hull HF, Hull BP, Kim-Farley RJ. The WHO-EPI initiative for the global eradication of poliomyelitis. Biologicals 1993; 21: Mubarak MH. A decade for the protection and development of the Egyptian child ( ). Cairo: Presidential Declaration, Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral polio vaccine in developing countries: review. Rev Infect Dis 1991; 13: Expanded Programme on Immunization. Global Advisory Group-Part II: achieving the major disease control goals. Wkly Epidemiol Rec 1994; 69: Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO POLIO FAQs on ENDGAME Tuberculosis AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO OBJECTIVES Brief history of poliomyelitis Polio eradication:

More information

Eradication of Wild Poliovirus from the Americas: Acute Flaccid Paralysis Surveillance,

Eradication of Wild Poliovirus from the Americas: Acute Flaccid Paralysis Surveillance, S37 Eradication of Wild Poliovirus from the Americas: Acute Flaccid Paralysis Surveillance, 1988-1995 Ciro A. de Quadros, Bradley S. Hersh, Jean-Marc Olive, Jon K. Andrus, Claudio M. da Silveira, and Peter

More information

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594 Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%

More information

Poliomyelitis eradication in the WHO European Region

Poliomyelitis eradication in the WHO European Region Provisional agenda item 6(i) EUR/RC60/16 (+EUR/RC60/Conf.Doc./9) 23 July 2010 101614 ORIGINAL: ENGLISH Poliomyelitis eradication in the WHO European Region WHO Regional Committee for Europe Sixtieth session

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA 4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION

More information

Global Polio Eradication & Endgame Strategy. December 2015

Global Polio Eradication & Endgame Strategy. December 2015 Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio

More information

INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION

INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION WORLD HEALTH ORGANIZATION Regional Office for South-East Asia New Delhi SEA/Polio/11 12 February 1998 RESTRICTED INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION

More information

Eradication of poliomyelitis

Eradication of poliomyelitis EXECUTIVE BOARD EB142/37 142nd session 27 November 2017 Provisional agenda item 6.4 Eradication of poliomyelitis 1. This report provides an update on the status of the four objectives of the Polio Eradication

More information

Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges

Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges S89 Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges Jon K. Andrus, Kaushik Banerjee, Barbara P. Hull, Jean

More information

IEAG Findings 5-6 December 2005

IEAG Findings 5-6 December 2005 IEAG Findings 5-6 December 005 Surveillance Quality Surveillance Indicators India 005* 5.47 8% Less than 60% 60% to 69% 70% to 79% 80% and above No AFP case * data as on 6th November 005 AFP cases India

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

Poliomyelitis: successful and critical issues in the eradication process

Poliomyelitis: successful and critical issues in the eradication process Vaccine Preventable Diseases in the Mediterranean Basin and Black Sea: immunization strategies and coverage in the general population and the newly arrived migrants the ProVacMed project Poliomyelitis:

More information

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy Regional Committee for the Eastern Mediterranean Sixtieth session Provisional agenda item 3 (a) August 2013 Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

More information

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide Global Overview Polio Partners Group, December 2015 1 Note: Gavi requirements of $122.2 million are not included in this slide The Polio Endgame Plan 1. Poliovirus detection & interruption 2. OPV2 withdrawal,

More information

National Action Plan for Response to Poliovirus Importation

National Action Plan for Response to Poliovirus Importation Public Health Res Perspect 2011 2(1), 65e71 doi:10.1016/j.phrp.2011.04.003 pissn 2210-9099 eissn 2233-6052 - BRIEF REPORT - National Action Plan for Response to Poliovirus Importation Kyung Min Song a,

More information

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine Polio Eradication a reconsideration of strategy D.A.Henderson, MD, MPH Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine Baltimore, Maryland

More information

Poliomyelitis Surveillance: The Compass for Eradication

Poliomyelitis Surveillance: The Compass for Eradication S146 Poliomyelitis Surveillance: The Compass for Eradication Maureen E. Birmingham, Robert W. Linkins, Barbara P. Hull, and Harry F. Hull Expanded Programme on Immunization, Global Programme for Vaccines

More information

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014 Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities Polio Partners Group 8 December 2014 Outline Progress Impact of Ebola Priorities Risks Wild Poliovirus type 1 (WPV1) Cases, 2013

More information

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus WHO statement 26 November The 7th meeting of the Emergency Committee under the International

More information

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12 5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Endgame Issues for the Global Polio Eradication Initiative

Endgame Issues for the Global Polio Eradication Initiative VIEWPOINTS Endgame Issues for the Global Polio Eradication Initiative Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis a The polio eradication initiative,

More information

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV Frequently Asked Questions February 2015 Table of Contents Rationale for OPV cessation... 2 About

More information

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges European Conference on Post Polio Syndrome 31 August 2 September 2011, Copenhagen, Denmark Dr Rebecca Martin Vaccine Preventable

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 1 Introduction: Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 2003-2008 1 Enhanced measles elimination activities in the Region of the Americas during the

More information

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments Introduction While polio exists anywhere, countries with low

More information

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Global and Regional update on Polio Eradication Activities Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Presentation Outline 1. Background information 2. Poliovirus detection & interruption

More information

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM Fact sheet Poliomyelitis WHO Media centre ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM Media centre Poliomyelitis Fact sheet Updated April 2016 Key

More information

Revisiting Old and Addressing Current Issues on Vaccines: POLIO

Revisiting Old and Addressing Current Issues on Vaccines: POLIO Revisiting Old and Addressing Current Issues on Vaccines: POLIO Maria Carmen B. Nievera MD Fellow, Pediatric Infectious Disease Society of the Philippines Fellow, Philippine Pediatric Society Regional

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Polio and routine immunisation Alan Brooks

Polio and routine immunisation Alan Brooks Polio and routine immunisation Alan Brooks Geneva, Switzerland, Background 1 History of polio eradication World Health Assembly Resolution 400 Previous eradication targets Polio cases (thousands) 300 200

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Global eradication of poliomyelitis

Global eradication of poliomyelitis WHO/EPI/GEN/98.04 ENGLISH ONLY DISTR.: GENERAL Global eradication of poliomyelitis Report of the second meeting of the Global Technical Consultative Group (TCG), 28 April 1997 GLOBAL PROGRAMME FOR VACCINES

More information

Progress in maternal and child health: Uzbekistan and WHO European Region

Progress in maternal and child health: Uzbekistan and WHO European Region Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN

More information

POLIO POST-CERTIFICATION STRATEGY. Summary overview 8 August 2017

POLIO POST-CERTIFICATION STRATEGY. Summary overview 8 August 2017 POLIO POST-CERTIFICATION STRATEGY Summary overview 8 August 2017 Introduction This PowerPoint is intended to provide a summary overview of the polio Post- Certification Strategy (PCS) 2021-2030, at its

More information

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort: International PolioPlus Committee PolioPlus Facts and Figures June 2018 1. The goal of the PolioPlus program: The goal of the PolioPlus program is the global certification of polio eradication. By eradication,

More information

3. CONCLUSIONS AND RECOMMENDATIONS

3. CONCLUSIONS AND RECOMMENDATIONS 3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the

More information

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 Polio Eradication in India Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 History of Polio in India Number of Cases 200,000 200,000 OPV Introduced in RI - 1978 150,000

More information

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand

More information

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

Why still Polio Donato Greco ECDC polio consultant 14 April 2016 Why still Polio Donato Greco ECDC polio consultant 14 April 2016 A medical student with the last texbook on Communicable diseases! Where there is no chapter on Poliomielitis!!! What can I say o Background

More information

Vaccination Recommendations for Travellers from Polio-infected Countries: Report of the SAGE Polio Working Group

Vaccination Recommendations for Travellers from Polio-infected Countries: Report of the SAGE Polio Working Group Vaccination Recommendations for Travellers from Polio-infected Countries: Report of the SAGE Polio Working Group Peter Figueroa, Chair SAGE Polio Working Group April 1, 2014 1 Overview Context for the

More information

Poliovirus : éradication pour les prochaines JNI?

Poliovirus : éradication pour les prochaines JNI? Poliovirus : éradication pour les prochaines JNI? Bruno LINA CNR des entérovirus Laboratoire de virologie EST, GHE, HCL FRE 3011 CNRS UCBL, Lyon Polio Eradication Initiative 1 Polio Eradication Progress

More information

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010 Polio vaccines and polio immunization in the pre-eradication era: WHO position paper Published in WER 4 June, 2010 Epidemiology & Background Poliomyelitis (polio) is an acute communicable disease of humans

More information

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella

More information

Achieving Polio Eradication in India. Emergency Preparedness and Response Plan 2011

Achieving Polio Eradication in India. Emergency Preparedness and Response Plan 2011 Achieving Polio Eradication in India Emergency Preparedness and Response Plan 2011 Emergency Preparedness and Response Plan 2011 The Emergency Preparedness and Response Plan has been developed at the request

More information

Progress report on. Eradication of poliomyelitis

Progress report on. Eradication of poliomyelitis Regional Committee for the EM/RC52/INF.DOC.2 Eastern Mediterranean August 2005 Fifty-second Session Original: Arabic Agenda item 4 (b) Progress report on Eradication of poliomyelitis Contents 1. Introduction...1

More information

Assessment of Guillain-Barre Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance

Assessment of Guillain-Barre Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance SI51 Assessment of Guillain-Barre Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance D. Rebecca Prevots and Roland W. Sutter National Immunization

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing

More information

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION. In the Name of God, the Compassionate, the Merciful Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION on the FIRST EMIRATES INTERNATIONAL CONFERENCE ON VACCINATION Dubai,

More information

keywords eradication, Madagascar, mass vaccination campaigns, poliomyelitis, seroprevalence

keywords eradication, Madagascar, mass vaccination campaigns, poliomyelitis, seroprevalence Tropical Medicine and International Health volume 6 no 12 pp 1032±1039 december 2001 Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children

More information

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods INTRODUCTION National Influenza Centres (NICs) are the backbone of the WHO Global Influenza Surveillance

More information

WHE Situation Report. June, 2018 Situation Report No M KEY FIGURES HIGHLIGHTS. There has been significant decrease in the

WHE Situation Report. June, 2018 Situation Report No M KEY FIGURES HIGHLIGHTS. There has been significant decrease in the WHE Situation Report 5.4 M In Need of Health Services KEY FIGURES 5.4M 2.6 M Displaced 4.3 M People Targeted 341 EWARN Sentinel Sites HIGHLIGHTS 5,582 Cholera Cases 49 WHO STAFF IN THE COUNTRY There has

More information

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB) EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb

More information

Expanded Programme on Immunization

Expanded Programme on Immunization 1 Expanded Programme on Immunization Strategic issues Immunization is a cost-effective public health intervention that has dramatically reduced disease, disability and death in the Western Pacifi c Region.

More information

Context 4.1 WHERE WE ARE TODAY. Figure 2: Countries with cases of wild poliovirus, 2011 and 2012

Context 4.1 WHERE WE ARE TODAY. Figure 2: Countries with cases of wild poliovirus, 2011 and 2012 POLIO ERADICATION & ENDGAME STRATEGIC PLAN 2013-2018 Context 4.1 WHERE WE ARE TODAY Figure 2: Countries with cases of wild poliovirus, 2011 and 2012 2011 2012 Data as of 19 February 2013 Countries with

More information

Status of Outbreak Vulnerable Countries

Status of Outbreak Vulnerable Countries Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries

More information

3/25/2018. End Polio Now an Update. Type 3 has not been seen since The Polio Virus. Polio What is it and Where did it Originate?

3/25/2018. End Polio Now an Update. Type 3 has not been seen since The Polio Virus. Polio What is it and Where did it Originate? End Polio Now an Update The Polio Virus Presentation to the Northern California Chapter American Microbiology Association Spring Meeting, March 2, 2018 Polio What is it and Where did it Originate? Polio

More information

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January

More information

Effectiveness of Immunization against Paralytic Poliomyelitis in Nigeria

Effectiveness of Immunization against Paralytic Poliomyelitis in Nigeria The new england journal of medicine original article Effectiveness of Immunization against Paralytic Poliomyelitis in Nigeria Helen E. Jenkins, M.Sc., R. Bruce Aylward, M.D., Alex Gasasira, M.B., Ch.B.,

More information

Efforts and Progress Towards Polio Elimination in the Americas and the World CRISTINA PEDREIRA, ELIZABETH THRUSH, AND BARBARA JAUREGUI

Efforts and Progress Towards Polio Elimination in the Americas and the World CRISTINA PEDREIRA, ELIZABETH THRUSH, AND BARBARA JAUREGUI Efforts and Progress Towards Polio Elimination in the Americas and the World CRISTINA PEDREIRA, ELIZABETH THRUSH, AND BARBARA JAUREGUI 2 Efforts and Progress Towards Polio Elimination in the Americas and

More information

Status of Poliomyelitis Eradication in Europe and the Central Asian Republics of the Former Soviet Union

Status of Poliomyelitis Eradication in Europe and the Central Asian Republics of the Former Soviet Union S76 Status of Poliomyelitis Eradication in Europe and the Central Asian Republics of the Former Soviet Union George Oblapenko and Roland W. Sutter Regional Office for Europe, World Health Organization,

More information

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 SUPPLEMENT ARTICLE Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 Patrick Michael O Connor, 1 Robert Allison, 1 Arun Thapa, 1 Sunil Bahl, 2 Supamit Chunsuittiwat,

More information

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)

More information

Global ProhrammeUpdate?

Global ProhrammeUpdate? Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus

More information

Maintaining Polio-Free Certification in the World Health Organization Western Pacific Region for Over a Decade

Maintaining Polio-Free Certification in the World Health Organization Western Pacific Region for Over a Decade SUPPLEMENT ARTICLE Maintaining Polio-Free Certification in the World Health Organization Western Pacific Region for Over a Decade Anthony Adams, 1 Liliane Boualam, 2 Sergey Diorditsa, 2 Christopher Gregory,

More information

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Report 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Kano, Nigeria 12-13 July 2006 Executive Summary The 10 th Expert Review Committee (ERC) met in Kano on 12-13 July

More information

Report of the Polio WG Meeting February Dr. Peter Figueroa Co-Chair, SAGE Polio Working Group 17 April, 2018

Report of the Polio WG Meeting February Dr. Peter Figueroa Co-Chair, SAGE Polio Working Group 17 April, 2018 Report of the Polio WG Meeting 20-21 February 2018 Dr. Peter Figueroa Co-Chair, SAGE Polio Working Group 17 April, 2018 Polio WG Discussions: Objectives To review progress towards global polio eradication

More information

Could a combination of OPV & IPV accelerate wild type poliovirus eradication? Nicholas Grassly

Could a combination of OPV & IPV accelerate wild type poliovirus eradication? Nicholas Grassly Could a combination of OPV & IPV accelerate wild type poliovirus eradication? Nicholas Grassly SAGE working group on IPV (est. Aug 2008) SAGE Members Elizabeth Miller, Chair Hyam Bashour Peter Figueroa

More information

Polio Eradication: The Difficult Inclusion of IPV. Research, Policy and Product Development (RAP), Polio Operations & Research Department (POL)

Polio Eradication: The Difficult Inclusion of IPV. Research, Policy and Product Development (RAP), Polio Operations & Research Department (POL) Polio Eradication: The Difficult Inclusion of IPV Research, Policy and Product Development (RAP), Polio Operations & Research Department (POL) Overview Historical context Early inequality in case burden

More information

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH Dr. Karen Lewis-Bell Advisor, Immunization Switch Monitoring Training Jamaica, December 9, 2015 Presentation Outline

More information

Selected vaccine introduction status into routine immunization

Selected vaccine introduction status into routine immunization Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF

More information

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210 EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine

More information

TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING. Gavi Board pre-meeting December 9, 2014, Geneva.

TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING. Gavi Board pre-meeting December 9, 2014, Geneva. TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING Gavi Board pre-meeting December 9, 2014, Geneva www.gavi.org SESSION OUTLINE Global polio eradication update Overview of Polio

More information

Eradicating Polio: It's Feasibility in Near Future?

Eradicating Polio: It's Feasibility in Near Future? J. Commun. Dis. 40 (4) 2008 : 225-232 Eradicating Polio: It's Feasibility in Near Future? Singh Prem*, Das JK*, Dutta PK* Abstract Continuous wild poliovirus transmission despite 2 years of intensive surveillance

More information

Polio Eradication Initiative Afghanistan

Polio Eradication Initiative Afghanistan Ministry of Public Health Polio Eradication Initiative Afghanistan 9 th IMB Meeting 01 October 2013 National Milestone for Polio Eradication 2013 Milestone 2012 Feb 2013 Aug 2013 Remarks Total unvaccinated

More information

Our Opportunity to make ZERO a Reality!

Our Opportunity to make ZERO a Reality! Pakistan Program Review Our Opportunity to make ZERO a Reality! Senator Ayesha Raza Farooq Prime Minister s Focal Person for Polio Eradication Polio Oversight Board New York, September 25 th 2015 Outline

More information

Pakistan & Afghanistan: Will we soon see the end of polio?

Pakistan & Afghanistan: Will we soon see the end of polio? Pakistan & Afghanistan: Will we soon see the end of polio? The view from the perspective of the Country Programs Christopher Maher Manager Polio Eradication WHO, EMRO PPG 5 December 2016 Current situation

More information

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September Polio: A Global Update DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September 27. 2017 1 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption 2. OPV2 withdrawal, IPV introduction,

More information

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712. EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced

More information

Polio Eradication: Beginning of the End, or End of the Beginning?

Polio Eradication: Beginning of the End, or End of the Beginning? Polio Eradication: Beginning of the End, or End of the Beginning? University of Colorado Jon Kim Andrus, MD Adjoint Professor and Director Vaccines and Immunization Center for Global Health University

More information

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC REPORT THE INFORMAL SIXTH MEETING OF THE SUBREGIONAL COMMITTEE FOR CERTIFICATION OF POLIOMYELITIS IN PACIFIC ISLAND COUNTRIES AND AREAS

More information

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes

More information

Table 1: Basic information 2017

Table 1: Basic information 2017 EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB

More information

Status of oral polio vaccination program for international travellers and its determinants: an experience from a designated centre of West Bengal

Status of oral polio vaccination program for international travellers and its determinants: an experience from a designated centre of West Bengal International Journal of Community Medicine and Public Health Sarkar M et al. Int J Community Med Public Health. 2017 Apr;4(4):1223-1229 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original Research

More information

Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions

Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions Muhammad T 1, SS Baba 2, LT Zaria 2, AD El-Yuguda 2 And IB Thilza 3, 1 who National Polio

More information

PART 1: General SOPs RESPONDING TO A POLIOVIRUS EVENT OR OUTBREAK STANDARD OPERATING PROCEDURES

PART 1: General SOPs RESPONDING TO A POLIOVIRUS EVENT OR OUTBREAK STANDARD OPERATING PROCEDURES STANDARD OPERATING PROCEDURES A POLIOVIRUS EVENT OR OUTBREAK PART 1: General SOPs V2.1 20 April 2016 V2.2 15 August 2016 V2.3 01 May 2017 EFFECTIVE 1 MAY 2017 UNTIL 31 OCTOBER 2017 Published by the World

More information

Syria cvdpv2 outbreak Situation Report # 18

Syria cvdpv2 outbreak Situation Report # 18 Syria cvdpv outbreak Situation Report # cvdpv cases in, and Homs governorates, Syria, 07 7 October 07 Summary New cvdpv cases this week: Total number of cvdpv cases: 5 Outbreak grade: Infected governorates

More information

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EURO POLIO PAGE Data as of 04 October 2005 (Week 38) World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:

More information

International Measles Incidence and Immunization Coverage

International Measles Incidence and Immunization Coverage SUPPLEMENT ARTICLE International Measles Incidence and Immunization Coverage Robert Hall and Damien Jolley Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine,

More information

VPD in Mediterranean Basin and Black Sea: the Polio case

VPD in Mediterranean Basin and Black Sea: the Polio case Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

ARTICLE IN PRESS Vaccine xxx (2010) xxx xxx

ARTICLE IN PRESS Vaccine xxx (2010) xxx xxx Vaccine xxx (2010) xxx xxx Contents lists available at ScienceDirect Vaccine journal homepage: www.elsevier.com/locate/vaccine Economic analysis of the global polio eradication initiative Radboud J. Duintjer

More information

Immunization Plus Days: Polio Eradication Initiative in Kaduna, Northern Nigeria. Nonso Njokanma September 19, 2006

Immunization Plus Days: Polio Eradication Initiative in Kaduna, Northern Nigeria. Nonso Njokanma September 19, 2006 Immunization Plus Days: Polio Eradication Initiative in Kaduna, Northern Nigeria Nonso Njokanma September 19, 2006 Outline Epidemiology of Wild Polio Virus (WPV) History of Global Polio Eradication Immunization

More information